Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease

Overview of attention for article published in Translational Neurodegeneration, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet

twitter: 6 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 32 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.

Alzforum, 06 May 2022

Morrone CD, Lai AY, Bishay J, Hill ME, McLaurin J. Transl Neurodegener. 2022 May 3;11(1):26.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.